Brain Peptide Shuttles
- 1st Edition, Volume 105 - February 1, 2026
- Latest edition
- Editors: Macarena Sanchez-Navarro, Barbara S. Slusher, Diane Peters, Benjami Oller-Salvi
- Language: English
Advances in Pharmacology, Volume 105, a new volume in this ongoing series, highlights new advances in the field, with this new volume presenting interesting chapters on a variet… Read more
Advances in Pharmacology, Volume 105, a new volume in this ongoing series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of topics, including Introduction to brain shuttle peptides, In silico optimization of brain shuttle properties for passive diffusion, Shuttles derived from natural proteins, Shuttles derived from phage display, Chemically enhanced brain shuttle peptides, Brain delivery of gold nanoparticles, Brain delivery of lipid nanoparticles, Brain delivery of therapeutic proteins, In vitro BBB models for the study of brain shuttle transport, Physiological strategies for delivery across the BBB, and Polymeric Nanoparticles.
- Provides the latest information on Pharmacology
- Offers outstanding and original reviews on a range of Pharmacology research topics
- Serves as an indispensable reference for researchers and students alike
Researchers, scientists, academicians
1. Introduction to brain shuttle peptides
Benjamí Oller-Salvia and Macarena Sánchez Navarro
2. In silico optimization of brain shuttle properties for passive diffusion
Daniela Kalafatovic, Patrizia Janković, Marko Njirjak, Nikolina Mohović and Ena Dražić
3. Shuttles derived from natural proteins
Toni Todorovski, Wadih Arap and Andrej Nikolić
4. Shuttles derived from phage display
Renata Pasqualini
5. Chemically enhanced brain shuttle peptides
Cristina Díaz
6. Brain delivery of gold nanoparticles
Marcelo Kogan
7. Brain delivery of lipid nanoparticles
Ronny Vargas-Monge, Noelia Martínez-Martínez, Laura Carrera-Rodríguez, Carlos Suñé and Marc Suñé-Pou
8. Brain delivery of therapeutic proteins
Marina Plaza-Garrido
9. In vitro BBB models for the study of brain shuttle transport
Fuzsina Walter
10. Physiological strategies for delivery across the BBB
Daniel Gonzalez Carter
11. Polymeric Nanoparticles
Elena Sanchez Lopez
Benjamí Oller-Salvia and Macarena Sánchez Navarro
2. In silico optimization of brain shuttle properties for passive diffusion
Daniela Kalafatovic, Patrizia Janković, Marko Njirjak, Nikolina Mohović and Ena Dražić
3. Shuttles derived from natural proteins
Toni Todorovski, Wadih Arap and Andrej Nikolić
4. Shuttles derived from phage display
Renata Pasqualini
5. Chemically enhanced brain shuttle peptides
Cristina Díaz
6. Brain delivery of gold nanoparticles
Marcelo Kogan
7. Brain delivery of lipid nanoparticles
Ronny Vargas-Monge, Noelia Martínez-Martínez, Laura Carrera-Rodríguez, Carlos Suñé and Marc Suñé-Pou
8. Brain delivery of therapeutic proteins
Marina Plaza-Garrido
9. In vitro BBB models for the study of brain shuttle transport
Fuzsina Walter
10. Physiological strategies for delivery across the BBB
Daniel Gonzalez Carter
11. Polymeric Nanoparticles
Elena Sanchez Lopez
- Edition: 1
- Latest edition
- Volume: 105
- Published: February 1, 2026
- Language: English
BS
Barbara S. Slusher
Barbara Slusher is a Professor of Neurology (primary), Pharmacology and Molecular Sciences, Psychiatry,
Neuroscience, Medicine, and Oncology at Johns Hopkins School of Medicine. She also serves as the Director of the Johns Hopkins Drug Discovery, the Vice Director of the Pedersen Brain Science Institute, and the Co-Director of the Johns Hopkins Center for the Advancement of HIV Neurotherapeutics (JH CAHN).
She has published over 300 scientific articles and is an inventor on over100 patents and applications. Before joining Johns Hopkins, she spent 18 years in the pharmaceutical industry, including several years at the level of Senior Vice President of Research and Translational Development. She has extensive experience in drug discovery through early clinical development and was involved in the successful development, launch and/or post marketing support of several FDA-approved medicines.
In 2010, she joined Johns Hopkins to lead the largest drug discovery program on campus with a veteran team of over 25 medicinal chemists, assay developers, pharmacologists, toxicologists, and pharmacokinetics/drug metabolism experts. The team identifies novel drug targets and translates them into new drug therapies for clinical development. Since joining JHU, she has co-founded four new companies which have amassed over $150M in financing and has partnered four new drug discovery programs with Pharma. She also founded the first International Consortium of Academic Drug Discovery Centers (http://addconsortium.org/) with over 150 university-led translational centers and 1500 members to bring together this growing community.
Dr. Slusher received her undergraduate degree from Dickinson College where she graduated valedictorian, majoring in Chemistry. She received her Ph.D. in Pharmacology and Molecular Sciences from the Johns Hopkins School of Medicine while simultaneously earning her Master's degree in Administrative Science from the Johns Hopkins Carey School of Business (formerly School of Continuing Studies).
Affiliations and expertise
Professor of Neurology, Pharmacology, Psychiatry, Neuroscience, Medicine, and Oncology Director, Johns Hopkins Drug Discovery Vice Director, Pederson Brain Science Institute Johns Hopkins School of Medicine, MD, USADP
Diane Peters
Diane Peters is an Assistant Professor of Pharmacology and Molecular Sciences at the Johns Hopkins School of Medicine. She received her BA in Chemistry, with honors, from Wellesley College, followed by pursuit of a PhD in Pharmacology and Experimental Therapeutics from the Tufts University School of Medicine. Subsequently, she earned an MS in laboratory animal medicine as well as a doctorate of veterinary medicine, both granted by the Tufts University School of Veterinary Medicine. Dr. Peters performed her post-graduate fellowship training in laboratory animal medicine at the Johns Hopkins University School of Medicine, where she further refined research expertise in comparative medicine, translational drug discovery, and animal pharmacology/toxicology.
Affiliations and expertise
Assistant Professor, Pharmacology and Molecular Sciences, Baltimore, MD, USA